Valeant Down 60%, But Ignore the Hype – It’s Definitely Not A Buy
Matt Argersinger and Jason Moser go over some of the company’s many red flags, and why it’s so important for individual investors to do their own research, instead of just repeating the moves of famous investors.
This podcast was recorded on Mar. 18, 2016.